Literature DB >> 29747903

Metabolic Hallmarks of Metastasis Formation.

Ilaria Elia1, Ginevra Doglioni1, Sarah-Maria Fendt2.   

Abstract

Metastasis to distant organs is a predictor of poor prognosis. Therefore, it is of paramount importance to understand the mechanisms that impinge on the different steps of the metastatic cascade. Recent work has revealed that particular metabolic pathways are rewired in cancer cells to support their transition through the metastatic cascade, resulting in the formation of secondary tumors in distant organs. Indeed, metabolic rewiring induces signaling pathways during initial cancer invasion, circulating cancer cells depend on enhanced antioxidant defenses, and cancer cells colonizing a distant organ require increased ATP production. Moreover, the local environment of the metastatic niche dictates the metabolic pathways secondary tumors rely on. Here we describe mechanisms of metabolic rewiring associated with distinct steps of metastasis formation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29747903     DOI: 10.1016/j.tcb.2018.04.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  65 in total

Review 1.  Metastasis Organotropism: Redefining the Congenial Soil.

Authors:  Yang Gao; Igor Bado; Hai Wang; Weijie Zhang; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

Review 2.  Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.

Authors:  Fuming Li; M Celeste Simon
Journal:  Dev Cell       Date:  2020-07-07       Impact factor: 12.270

3.  Cancer cells stock up in lymph vessels to survive.

Authors:  Barbara M Grüner; Sarah-Maria Fendt
Journal:  Nature       Date:  2020-09       Impact factor: 49.962

Review 4.  Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 5.  Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.

Authors:  Patricia Altea-Manzano; Alejandro M Cuadros; Lindsay A Broadfield; Sarah-Maria Fendt
Journal:  EMBO Rep       Date:  2020-09-23       Impact factor: 8.807

6.  Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing.

Authors:  Ryan T Davis; Kerrigan Blake; Dennis Ma; Mari B Ishak Gabra; Grace A Hernandez; Anh T Phung; Ying Yang; Dustin Maurer; Austin E Y T Lefebvre; Hamad Alshetaiwi; Zhengtao Xiao; Juan Liu; Jason W Locasale; Michelle A Digman; Eric Mjolsness; Mei Kong; Zena Werb; Devon A Lawson
Journal:  Nat Cell Biol       Date:  2020-03-06       Impact factor: 28.824

7.  KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL.

Authors:  Cody N Rozeveld; Katherine M Johnson; Lizhi Zhang; Gina L Razidlo
Journal:  Cancer Res       Date:  2020-08-19       Impact factor: 12.701

Review 8.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04

Review 9.  The metabolism of cancer cells during metastasis.

Authors:  Gabriele Bergers; Sarah-Maria Fendt
Journal:  Nat Rev Cancer       Date:  2021-01-18       Impact factor: 60.716

10.  Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism.

Authors:  Rosanna Dattilo; Carla Mottini; Emanuela Camera; Alessia Lamolinara; Noam Auslander; Ginevra Doglioni; Michela Muscolini; Wei Tang; Melanie Planque; Cristiana Ercolani; Simonetta Buglioni; Isabella Manni; Daniela Trisciuoglio; Alessandra Boe; Sveva Grande; Anna Maria Luciani; Manuela Iezzi; Gennaro Ciliberto; Stefan Ambs; Ruggero De Maria; Sarah-Maria Fendt; Eytan Ruppin; Luca Cardone
Journal:  Cancer Res       Date:  2020-07-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.